课题基金 / 基金详情

The development of tissue engineering procedure for osteogensesis -investigation using plate rich plasma and mesenchymal stem cell-

The development of tissue engineering procedure for osteogensesis -investigation using plate rich plasma and mesenchymal stem cell-
成骨组织工程程序的开发 - 使用富含平板的血浆和间充质干细胞进行研究 -
批准号:
17390416
负责人:
ISHIGURO Naoki
金额:
$9.63万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

ISHIGURO Naoki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Distraction osteogenesis (DO) has become a widely used and accepted procedure in patients with limb length discrepancy or large bone defect, but the treatment period is long which results in higher rates of complications. Good bone formation during DO is essential to minimize the treatment time and reduce associated complications. We considered that DO is good model for investigating the biology of osteogensis. Tissue engineering strategy, which consists of three essential components (application of osteogenic cells, osteoinductive factors, and a scaffold), has emerged as a possible alternative to accelerate bone regeneration at the distracted gap.Bone marrow-derived mesenchymal stem cells(BMC)can be directed towards the osteogenic lineage if cultured in the presence of dexamethasone. Osteogenic potential can be maintained even in BMSCs that have been passaged several times in the presence of hrBMP-2. Platelet rich plasma(PRP)contains several osteoinductive growth factors including pla … More telet-derived growth factor, insulin-like growth factor, and transforming growth factors. PRP increased the number of BMC, but did not promote osteogenic potential in cultured BMC cells. Several investigators have reported that the injection of cells into the distracted callus enhanced bone formation However, the injected cells may move to the surrounding tissue, leading to a reduced concentration in the target area. Therefore, the scaffold is important factor. We concluded PRP can be a suitable carrier for cell transplantation because it coagulates immediately by an addition of thrombin and calcium from our studies. The weight bearing and movement may be another factor to develop osteogenesis in DO. We revealed that the weight bearing with distracted leg stimulated bone formation compared to non-weight bearing condition.For the clinical application of BMC based therapy, autologous PRP was used to prevent disease transmission and immunoreactions. The transplantation of BMC and PRP during DO may be regarded as promising procedure. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1080/17453670710013816
发表时间: 2007-01-01
期刊: ACTA ORTHOPAEDICA
影响因子: 3.7
作者: [Ishikawa, Hisato, Kitoh, Hiroshi, Ishiguro, Naoki]
通讯作者: Ishiguro, Naoki
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [T. Masui, S. Sakano, Y. Hasegawa, J. Yamaguchi, T. Kanoh, N. Ishiguro]
通讯作者: N. Ishiguro
DOI: --
发表时间: 2005
期刊: Br J Pharmacol 145(3)
影响因子: --
作者: [Amma H, Naruse K, Ishiguro N, Sokabe M]
通讯作者: Sokabe M
DOI: 10.1016/j.jbiotec.2007.07.955
发表时间: 2008-01-20
期刊: JOURNAL OF BIOTECHNOLOGY
影响因子: 4.1
作者: [Hirano, Yuji, Ishiguro, Naoki, Naruse, Keiji]
通讯作者: Naruse, Keiji
29
    Development of a new therapeutic drug for osteoarthritis that has a cartilage-protecting effect by inhibiting Wnt/ADAM10
    • 批准号:
      19H03779
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.98万
    • 财政年份:
      2019
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    TRPV4, a Ca ion channel plays pivotal role in chondrogenic mechanotransduction in ATDC5
    • 批准号:
      24659671
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2012
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    The research of the drugs that can promote SOX9m RNA expression in chondrocyte
    • 批准号:
      22659269
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.98万
    • 财政年份:
      2010
    • 负责人:
      ISHIGURO Naoki
    • 依托单位:
    The Research of the bioreactor that can promote the cell differentiation from bone marrow stem cells to osteogenic cells
    • 批准号:
      21390419
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.57万
    • 财政年份:
      2009
    • 负责人:
      ISHIGURO Naoki
    • 依托单位: